Get the SPI Wire

BONE BIOLOGICS CORPORATION

NASDAQ:BBLG
Annual Meeting

of Shareholders

MEETING DATE

09/28/2026
DEF 14A FILED
08/28/2026
PUBLISHED
08/28/2026 9:27 pm
TIME TO PUBLISH
08/30/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:BBLG · CUSIP 098070600 · CLASS Common Stock, par value $0.001 per share · CIK 0001419554

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

6
FOR
0
AGAINST
0
WITHHOLD
6
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of four directors: Bruce Stroever, Siddhesh Angle, Robert Gagnon and Phil Meikle
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the Board proposes these four current directors for election.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Advisory vote on executive compensation
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states stockholders are asked to approve named executive officer compensation as disclosed.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Ratification of appointment of Weinberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending December 31, 2026
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Audit Committee determined Weinberg & Company services are compatible with maintaining independence.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Approval of the potential issuance of shares underlying certain warrants
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states approval enables potential warrant exercise and approximately $6.0 million of additional gross proceeds.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Approval of amendment to the Charter to effect a reverse stock split of the common stock at the discretion of the Board
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the primary purpose is to maintain Nasdaq listing of common stock and certain warrants.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Approval of adjournment of the Annual Meeting
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states adjournment may be necessary if votes are insufficient or a quorum is absent.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

d19e51eb9c1d826c68a389ded0a256dff63eec509338055e270ed42628600a65

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates